RAANANA, Israel (Reuters) – Israel’s UroGen Pharma plans to begin a mid-stage trial of its treatment for bladder cancer patients in August, after positive interim results last month from an advanced trial of a treatment for upper urinary tract cancer.
COPENHAGEN (Reuters) – Novo Nordisk’s experimental diabetes pill, which it hopes will transform the diabetes market, has proved superior to both Merck & Co’s Januvia and its own best-selling injectable treatment Victoza in tests.
TORONTO (Reuters) – Marijuana sales will become legal in Canada beginning October 17, Prime Minister Justin Trudeau said on Wednesday, making it the first major economy to legalize its recreational use.
(Reuters Health) – Older adults who are faster on their feet may be less likely to suffer cognitive problems after heart surgery than patients who have difficulty walking, a Japanese study suggests.
(Reuters Health) – Children and adults who take five commonly prescribed types of antibiotics may be more likely to develop kidney stones than people who don’t use these medicines, a recent study suggests.
TORONTO (Reuters) – Cannabis sales will become legal in Canada from October 17, Prime Minister Justin Trudeau said on Wednesday, making it the first major economy to legalize recreational use or marijuana.
(Reuters Health) – Even when the heart rhythm disorder known as atrial fibrillation goes away after treatment, patients’ risk of stroke may still be higher than average, a large UK study suggests.
(Reuters Health) – Using non-steroidal anti-inflammatory drugs (NSAIDs) around the time of conception significantly increases the risk of miscarriage in the first eight weeks of pregnancy, a study suggests.
TORONTO (Reuters) – Canadian marijuana stocks rose on Wednesday after the country became the first major economy to legalize its recreational use, but earlier rallies in anticipation of victory in the key upper house vote muted some post-approval gains…
GOSPORT, England (Reuters) – More than 450 patients died prematurely in a British hospital after they were given powerful painkillers with no medical justification, in what a damning report on Wednesday found was a “disregard for human life”.
GOSPORT (Reuters) – More than 450 patients died prematurely in a British hospital after they were given powerful painkillers for no medical reason in what a damning report found was a “disregard for human life”.
LONDON (Reuters) – GlaxoSmithKline is taking its fight with Gilead Sciences for dominance of the HIV market to the world’s leading AIDS conference next month by showcasing detailed results from its new two-drug treatment.
GENEVA (Reuters) – Democratic Republic of Congo’s Ebola outbreak has been “largely contained” and no new cases of the disease have been confirmed since the last known sufferer died on June 9, the World Health Organization said on Wednesday.
PARIS (Reuters) – Sanofi missed the boat on immune system-boosting cancer drugs. Now it’s trying to catch up.
TORONTO (Reuters) – Canada’s upper house of parliament on Tuesday approved a revised bill to legalize recreational marijuana, setting the stage for the country to become the first Group of Seven nation to legalize cannabis.
(Reuters Health) – For young adults, the adverse effect of negative social media experiences on mental health outweigh any potential benefits of positive experiences, a study of university students suggests.
(Reuters Health) – Fathers’ use of antidepressant medications around the time mothers become pregnant does not increase babies’ risk of preterm birth, birth defects, autism or intellectual disability, according to a study in the BMJ.
(Reuters Health) – People who suffer from posttraumatic stress disorder (PTSD) and other stress-related psychiatric issues may be more likely to develop autoimmune diseases than individuals who don’t, a Swedish study suggests.
(Reuters) – Sarepta Therapeutics’ shares jumped 60 percent on Tuesday after promising results from a gene therapy study positioned the specialty drugmaker as a potential leader in the market for Duchenne muscular dystrophy (DMD) treatments.
(Reuters Health) – Severe obesity rates have been on the rise nationwide since the turn of the century, disproportionately affecting children and adults in rural communities, two U.S. studies suggest.